IL323739A - טבליה המכילה 6-((5-מתיל-3-(6-מתילפירידין-3-יל)איזוקסאזול-4-יל)מתוקסיל)-n-(טטרהידראפיראן-4-יל)פירידזין-3-קרבוקסמיד - Google Patents

טבליה המכילה 6-((5-מתיל-3-(6-מתילפירידין-3-יל)איזוקסאזול-4-יל)מתוקסיל)-n-(טטרהידראפיראן-4-יל)פירידזין-3-קרבוקסמיד

Info

Publication number
IL323739A
IL323739A IL323739A IL32373925A IL323739A IL 323739 A IL323739 A IL 323739A IL 323739 A IL323739 A IL 323739A IL 32373925 A IL32373925 A IL 32373925A IL 323739 A IL323739 A IL 323739A
Authority
IL
Israel
Prior art keywords
weight
kernel
total weight
tablet
filler
Prior art date
Application number
IL323739A
Other languages
English (en)
Inventor
Felix Ditzinger
Reto Maurer
Original Assignee
Hoffmann La Roche
Felix Ditzinger
Reto Maurer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Felix Ditzinger, Reto Maurer filed Critical Hoffmann La Roche
Publication of IL323739A publication Critical patent/IL323739A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL323739A 2023-04-24 2025-09-30 טבליה המכילה 6-((5-מתיל-3-(6-מתילפירידין-3-יל)איזוקסאזול-4-יל)מתוקסיל)-n-(טטרהידראפיראן-4-יל)פירידזין-3-קרבוקסמיד IL323739A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23169355 2023-04-24
PCT/EP2024/060856 WO2024223450A1 (en) 2023-04-24 2024-04-22 Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide

Publications (1)

Publication Number Publication Date
IL323739A true IL323739A (he) 2025-11-01

Family

ID=86184883

Family Applications (1)

Application Number Title Priority Date Filing Date
IL323739A IL323739A (he) 2023-04-24 2025-09-30 טבליה המכילה 6-((5-מתיל-3-(6-מתילפירידין-3-יל)איזוקסאזול-4-יל)מתוקסיל)-n-(טטרהידראפיראן-4-יל)פירידזין-3-קרבוקסמיד

Country Status (9)

Country Link
EP (1) EP4701621A1 (he)
JP (1) JP2026513673A (he)
KR (1) KR20250169340A (he)
CN (1) CN121001709A (he)
AU (1) AU2024262426A1 (he)
IL (1) IL323739A (he)
MX (1) MX2025012538A (he)
TW (1) TW202506123A (he)
WO (1) WO2024223450A1 (he)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA48594B1 (fr) 2016-12-08 2022-05-31 Hoffmann La Roche Nouveaux dérivés d'éther d'isoxazolyle en tant que pam alpha5 gaba a

Also Published As

Publication number Publication date
AU2024262426A1 (en) 2025-09-18
TW202506123A (zh) 2025-02-16
WO2024223450A1 (en) 2024-10-31
JP2026513673A (ja) 2026-04-30
EP4701621A1 (en) 2026-03-04
CN121001709A (zh) 2025-11-21
MX2025012538A (es) 2025-11-03
KR20250169340A (ko) 2025-12-02

Similar Documents

Publication Publication Date Title
JP5296456B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2008503475A (ja) メマンチンの放出が改変された製剤
EP2251005A1 (en) Orally disintegrating tablets
JP2012517458A (ja) リナグリプチン及び必要に応じてsglt2阻害薬を含む医薬組成物、並びにその使用
JP5656258B2 (ja) ガランタミンを含有する口腔内崩壊錠剤
US20090099203A1 (en) Composition 064
JP6919119B2 (ja) 3位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
JP2010270110A (ja) ネオテームを含有する経口製剤
WO2016051782A1 (ja) 苦味を有する薬剤の苦味をマスキングした経口投与製剤
HK1245646A1 (zh) 口服给药用医药组合物
JP6803250B2 (ja) エレトリプタン臭化水素酸塩含有口腔内崩壊錠
US20210244730A1 (en) Pharmaceutical composition containing an antitumor agent
US20140343076A1 (en) Pharmaceutical compositions of lurasidone
WO2026103205A1 (zh) 一种匹莫范色林或其盐的口崩片及其制备方法
US20230201234A1 (en) Fast dispersible pharmaceutical composition comprising capecitabine
EP3930691B1 (en) Pharmaceutical composition containing acetominophen and ibuprofen
WO2007144902A1 (en) Chewable bilayer tablet formulation
WO2024223450A1 (en) Tablet comprising 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)- n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide
JP5978335B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
TW202135802A (zh) 包含吡咯羧醯胺之口腔崩散錠
WO2004096214A1 (en) A rapidly disintegrable composition for masking the bitter taste of ondansetron or a pharmaceutically acceptable salt thereof
JP2017141299A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
RU2633477C2 (ru) Таблетка, содержащая гидрат метансульфоната 1-циклопропил-8-(дифторметокси)-7-[(1r)-1-метил-2, 3-дигидро-1н-изоиндол-5-ил]-4-оксо-1, 4-дигидрохинолин-3-карбоновой кислоты
US20060034911A1 (en) New oral immediated release dosage form
HK40128711A (zh) 包含6-((5-甲基-3-(6-甲基吡啶-3-基)异恶唑-4-基)甲氧基)-n-(四氢吡喃-4-基)哒嗪-3-甲酰胺的片剂